Related Experiment Video
Updated: Jul 4, 2026

06:31
Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Dispelling the myths behind pediatric patch testing-experience from our tertiary care patch testing centers.
Sharon E Jacob1, Tace Steele, Bruce Brod
1Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida, USA. sjacob@contactderm.net
Pediatric Dermatology
|June 26, 2008
Summary
Allergic contact dermatitis is common in children, but patch testing techniques are optimized for adults. This review highlights challenges and calls for pediatric-specific research to improve diagnosis.
Area of Science:
- Pediatric Dermatology
- Allergen Exposure
- Immunology
Background:
- Allergic contact dermatitis (ACD) affects up to 20% of children with dermatitis.
- Prevalence in referred children ranges from 25% to 60% via patch testing.
- Current patch testing methods are primarily based on adult studies.
Purpose of the Study:
- To address misconceptions and challenges in pediatric patch testing.
- To highlight the need for pediatric-specific diagnostic approaches.
- To stimulate research into optimized patch testing for children.
Main Methods:
- Review of existing literature on pediatric allergic contact dermatitis.
- Analysis of current epicutaneous patch test protocols.
- Identification of knowledge gaps in pediatric dermatological testing.
Main Results:
- Pediatric patch testing faces unique challenges due to anatomical and physiological differences.
- Standard adult protocols may not be optimal for accurate ACD diagnosis in children.
- Limited data exists on age-specific allergen reactivity and patch test responses.
Conclusions:
- Current patch testing practices for pediatric allergic contact dermatitis require critical evaluation.
- Further research is essential to establish evidence-based, optimized patch testing guidelines for children.
- Improving diagnostic accuracy is crucial for effective management of ACD in pediatric populations.

